Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Medicine
|
March 22, 2019
Relationship between arterial stiffness and circadian pattern of blood pressure
Jin-Sun Park, Joon-Han Shin, Jeong-Bae Park, et al.
Medicine
|
October 12, 2022
Central hemodynamics and the discrepancy between central blood pressure and brachial blood pressure
Jin-Sun Park, Joon-Han Shin, Jeong-Bae Park, et al.
Plos One
|
July 15, 2016
Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry
Sang-Don Park, Jeonggeun Moon, Sung Woo Kwon, et al.
International Heart Journal
|
September 14, 2020
Ivabradine-Induced Torsade de Pointes in Patients with Heart Failure Reduced Ejection Fraction
Ji-Hun Jang, Sung Woo Kwon, Man-Jong Lee, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 6, 2012
Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study
Chang-Gyu Park, Ho-Joong Youn, Shung-Chull Chae, et al.
Journal of Korean Medical Science
|
January 17, 2014
A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction
Jun-Won Lee, Seung-Hwan Lee, Young-Jin Youn, et al.
Medicine
|
September 15, 2018
A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy
Youngkeun Ahn, Yongcheol Kim, Kiyuk Chang, et al.
Clinical Therapeutics
|
December 26, 2007
Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia
Sang Hak Lee, Namsik Chung, Jun Kwan, et al.
International Journal of Cardiology
|
October 4, 2015
Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial
Pyung Chun Oh, Taehoon Ahn, Dong Woon Kim, et al.
Clinical Therapeutics
|
August 1, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Medicine
|
March 22, 2019
Relationship between arterial stiffness and circadian pattern of blood pressure
Jin-Sun Park, Joon-Han Shin, Jeong-Bae Park, et al.
Medicine
|
October 12, 2022
Central hemodynamics and the discrepancy between central blood pressure and brachial blood pressure
Jin-Sun Park, Joon-Han Shin, Jeong-Bae Park, et al.
Plos One
|
July 15, 2016
Prognostic Impact of Combined Contrast-Induced Acute Kidney Injury and Hypoxic Liver Injury in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results from INTERSTELLAR Registry
Sang-Don Park, Jeonggeun Moon, Sung Woo Kwon, et al.
International Heart Journal
|
September 14, 2020
Ivabradine-Induced Torsade de Pointes in Patients with Heart Failure Reduced Ejection Fraction
Ji-Hun Jang, Sung Woo Kwon, Man-Jong Lee, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
January 6, 2012
Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study
Chang-Gyu Park, Ho-Joong Youn, Shung-Chull Chae, et al.
Journal of Korean Medical Science
|
January 17, 2014
A randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction
Jun-Won Lee, Seung-Hwan Lee, Young-Jin Youn, et al.
Medicine
|
September 15, 2018
A multicenter, randomized, and double-blind phase IV clinical trial to compare the efficacy and safety of fixed-dose combinations of amlodipine orotate/valsartan 5/160 mg versus valsartan/hydrochlorothiazide 160/12.5 mg in patients with essential hypertension uncontrolled by valsartan 160 mg monotherapy
Youngkeun Ahn, Yongcheol Kim, Kiyuk Chang, et al.
Clinical Therapeutics
|
December 26, 2007
Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia
Sang Hak Lee, Namsik Chung, Jun Kwan, et al.
International Journal of Cardiology
|
October 4, 2015
Comparative effect on platelet function of a fixed-dose aspirin and clopidogrel combination versus separate formulations in patients with coronary artery disease: A phase IV, multicenter, prospective, 4-week non-inferiority trial
Pyung Chun Oh, Taehoon Ahn, Dong Woon Kim, et al.
Clinical Therapeutics
|
August 1, 2021
Comparison of the Efficacy and Safety of Atorvastatin 40 mg/ω-3 Fatty Acids 4 g Fixed-dose Combination and Atorvastatin 40 mg Monotherapy in Hypertriglyceridemic Patients who Poorly Respond to Atorvastatin 40 mg Monotherapy: An 8-week, Multicenter, Randomized, Double-blind Phase III Study
Jong Shin Woo, Soon Jun Hong, Dong Hoon Cha, et al.
Page
of 8